Company
United StatesPublic company, NASDAQ: MDXGMiMedx Group, Inc. (NASDAQ: MDXG), Kennesaw, GA – FDA Inspections
Inspection records and compliance data for MiMedx Group, Inc. in Kennesaw, Georgia. 3 FDA inspections on record (1 OAI), 1 Form 483, 1 warning letter, last inspected March 02, 2023. Publicly traded as NASDAQ: MDXG.
Company Profile
This profile covers MiMedx Group, Inc. based in Kennesaw, Georgia, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 1
- VAI
- 1
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 1
First inspected September 26, 2018. Last inspected March 2, 2023.
Most cited issue areas
- Absence of Written Procedures1 inspection
- Adequate number of batches on stability1 inspection
- Aseptic Processing Area1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 2, 2023 | OAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1198732 |
| December 12, 2019 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1112843 |
| September 26, 2018 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1069242 |
FDA documents
Warning Letters (1)
People (5)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
MiMedx Group, Inc.
Stock ticker
MDXG
Exchange
NASDAQ
Share price
$3.24
Market cap
$472.8M
Price as of
November 13, 2026
FEI Number
3009814715
Address
300 Townpark Dr Nw Ste 260, Kennesaw, Georgia 30144, United States
Country
United States
ID: 48cc856a-f21d-4488-bbbd-4428f7bf1308